Tempus AI
Update in progressTEM (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryHealth Information Services
Tempus AI, Inc. is a U.S. healthcare technology company that provides the Tempus platform—an integrated, bi-directional link between clinicians, laboratory diagnostics, analytics, and multimodal data. It also offers Hub for clinical workflows, Lens for life sciences research, and comprehensive NGS/molecular pathology testing, including large-panel DNA/RNA analyses. The company licenses Insights data, runs Trials matching, and develops AI tools like Next and Algos. Headquartered in Chicago, founded 2015.
Company score
- Sentiment
- 0.57
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.01
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.33
- Governance
- 0.17
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.14
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.35
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNasdaqGS (NMS)
- LocationUnited States
- CEOMr. Eric P. Lefkofsky J.D.
- Founded2015
- Employees3,800
- Websitewww.tempus.com
Identifiers
- ISINUS88023B1035
- FIGIBBG01MZQYJF9